[PDF][PDF] Update on innate and adaptive immunity in cystic fibrosis

EM Bruscia, TL Bonfield - Clinics in Chest Medicine, 2022 - Elsevier
Cystic fibrosis (CF) pathophysiology is hallmarked by excessive inflammation and the
inability to efficiently resolve lung infections, contributing to morbidly and eventually the …

Should we interfere with the interleukin-6 receptor during COVID-19: what do we know so far?

A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui… - Drugs, 2023 - Springer
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …

[HTML][HTML] Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: a multicenter retrospective research network study

YB Hadi, DA Lakhani, SF Naqvi, NU Fatima… - Respiratory …, 2021 - Elsevier
Background In this study, we report clinical outcomes in COVID-19 infection in a large cohort
of people with cystic fibrosis (pwCF) and compare these outcomes to a propensity score …

[HTML][HTML] Discovering common pathophysiological processes between COVID-19 and cystic fibrosis by differential gene expression pattern analysis

MT Hasan, LF Abdulrazak, MK Alam… - BioMed Research …, 2022 - ncbi.nlm.nih.gov
Coronaviruses are a family of viruses that infect mammals and birds. Coronaviruses cause
infections of the respiratory system in humans, which can be minor or fatal. A comparative …

[PDF][PDF] Children with cystic fibrosis hospitalised with Covid‐19: Multicentre experience

LS Al Yazidi, N Al Maskari… - Journal of Paediatrics and …, 2021 - researchgate.net
The Centres for Disease Control and prevention listed cystic fibrosis (CF) among
comorbidities which predispose children to severe COVID-19. 1 Respiratory viruses can …

Inhibiteurs du récepteur de l'IL-6 dans le traitement de la COVID-19: que savons-nous?

C Lefèvre, A Plocque, M Tran, M Creux… - Revue des Maladies …, 2023 - Elsevier
Résumé La COVID-19 est une infection virale à tropisme respiratoire majeur. Dans les
formes les plus sévères, l'agression virale initiale va conduire à une insuffisance respiratoire …

Inhibiteurs du récepteur de l'IL-6 dans le traitement de la COVID-19: que savons-nous? Should we interfere with the interleukin-6 receptor during COVID-19: What do …

C Lefèvre, A Plocque, M Tran, M Creux… - Revue des Maladies …, 2022 - europepmc.org
Résumé La COVID-19 est une infection virale à tropisme respiratoire majeur. Dans les
formes les plus sévères, l'agression virale initiale va conduire à une insuffisance respiratoire …